Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Hypertension. 2014 Aug 25;64(5):1094–1101. doi: 10.1161/HYPERTENSIONAHA.114.04282

Table 4.

Raw (unstandardized) regression coefficients (b) and standard error (SE) summarizing associations between overall variability in BP* (SD) and cognitive functioning measures, stratified by hypertension status

Cognitive outcome Predictor Hypertension, controlled,
n=289 (29.7%)
Hypertension, uncontrolled,
n=195 (20.1%)

b SE P b SE P
Global Composite Variability SBP −.010 .014 .490 −.040 .017 .021
Variability DBP −.021 .024 .386 −.073 .023 .002
Visual Spatial Memory and Organization Variability SBP −.014 .015 .354 −.029 .018 .097
Variability DBP −.028 .026 .277 −.085 .023 <.001
Similarities Variability SBP −.001 .016 .932 −.045 .019 .020
Variability DBP .033 .027 .226 −.072 .026 .005
Mini-Mental State Examination Variability SBP −.006 .014 .696 −.070 .022 .002
Variability DBP .002 .024 .935 −.058 .030 .057

DBP indicates diastolic blood pressure; SBP, systolic blood pressure.

Presented data are for the extended model; regression coefficients were adjusted for age, education, gender, ethnicity, diabetes, pulse pressure, BMI, total cholesterol, smoking (Y/N), alcohol (Y/N).

*

Overall variability calculated as the SD of all 15 individual BP measures.

Hypertension defined as BP ≥140/90 mmHg or being treated with anti-hypertensive medication; controlled defined as BP <140/90 mmHg while on medication; uncontrolled defined as BP ≥140/90 mmHg while on medication.